Editorials

Parkinson's disease genetics comes of age

BMJ 1999; 318 doi: https://doi.org/10.1136/bmj.318.7199.1641 (Published 19 June 1999) Cite this as: BMJ 1999;318:1641

Knowledge about genes in familial parkinsonism helps elucidate idiopathic disease

  1. Paul Jarman, Research fellow,
  2. Nicholas Wood, Reader
  1. Department of Clinical Neurology, Institute of Neurology, London WC1N 3BG

    Parkinson's disease is a neurodegenerative disorder in which loss of dopaminergic cells in the pars compacta of the substantia nigra is recognised to be a central pathological event. Despite several decades of intensive research, however, its cause remains unknown. Although not usually thought of as a hereditary disorder, accumulating evidence suggests a significant genetic component for susceptibility to idiopathic Parkinson's disease. Population based epidemiological studies indicate that the risk of Parkinson's disease is at least doubled in first degree relatives of patientscompared with controls, while hospital based studies suggest a higher risk. 1 2 The lifetime risk in first degree relatives of sporadic cases is estimated to be as high as 17%.3

    A molecular genetic approach to the study of Parkinson's disease has been hampered by the relative scarcity of large kindreds with familial Parkinson's disease and the difficulty of obtaining DNA for analysis from more than one generation in this late onset disorder. Despite these difficulties this approach has finally begun to bear fruit. By using as a starting point families in which parkinsonism is clearly inherited as a mendelian trait, three genes for Parkinson's disease have recently been characterised.46 …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe